Ontology highlight
ABSTRACT: Background
Clinical, pathologic, and molecular evidence indicate that bladder cancer is heterogeneous with pathologic/molecular features that define distinct subphenotypes with different prognoses. It is conceivable that specific patterns of genetic susceptibility are associated with particular subphenotypes.Objective
To examine evidence for the contribution of germline genetic variation to bladder cancer heterogeneity.Design, setting, and participants
The Spanish Bladder Cancer/EPICURO Study is a case-control study based in 18 hospitals located in five areas in Spain. Cases were patients with a newly diagnosed, histologically confirmed, urothelial cell carcinoma of the bladder from 1998 to 2001. Case diagnoses were reviewed and uniformly classified by pathologists
SUBMITTER: Guey LT
PROVIDER: S-EPMC3220186 | biostudies-literature | 2010 Feb
REPOSITORIES: biostudies-literature